Moderna Shares Crater on Huge Revenue Miss, Massive Guidance Cut

    0
    14

    Vaccine giant’s shares plunge 10% amid reports of rare side effects, new government restrictions, production struggles

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here